Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, April 19, 2024.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Long-Term Downtrend (-90) - XERS is in a strong downtrend that is likely to continue. While XERS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been DOWN since Apr 8th, 2024 at 2.0000
The intermediate-term trend has been DOWN since Mar 6th, 2024 at 2.7600
The short-term trend has been DOWN since Apr 3rd, 2024 at 2.0625
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.76 | 1.78 | 1.69 | 1.74 | -0.02 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.76 | 1920995 | 2024-04-19 15:59:58 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 3.26 | 52wk High Date | 2024-02-15 |
| 52wk Low | 1.46 | 52wk Low Date | 2023-11-15 |
| Average Volume | 1,456,400 | Shares Outstanding | 140,453 |
| Market Cap | 275M | Assets | 322,602,000M |
| Liabilities | 329,384,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |